Department of Pediatrics, University of Rochester School of Medicine and Dentistry, Rochester, New York;
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania; and.
Pediatrics. 2021 Mar;147(3). doi: 10.1542/peds.2020-013300. Epub 2021 Feb 3.
Transmasculine individuals, those assigned female sex at birth but who identify as masculine, have high rates of suicidal behavior and often suffer from chest dysphoria (discomfort and distress from unwanted breast development). Growing numbers of transmasculine youth are pursuing definitive treatment with masculinizing chest surgery (MCS), and adult studies reveal marked benefits of MCS, although little is known about the impact of chest dysphoria on transmasculine youth or the optimal timing of MCS. In this study, we aimed to explore youth experiences of chest dysphoria and the impact of MCS.
Transmasculine youth aged 13 to 21 were recruited from a pediatric hospital-based gender clinic. Participants completed a semistructured qualitative interview exploring the experience of chest dysphoria and thoughts about or experiences with MCS. Interview transcripts were coded by 3 investigators employing modified grounded theory, with the median interrater reliability at κ = 0.92.
Subjects ( = 30) were a mean age of 17.5 years, and 47% had undergone MCS. Youth reported that chest dysphoria triggered strong negative emotions and suicidal ideation, caused a myriad of functional limitations, and was inadequately relieved by testosterone therapy alone. All post-MCS youth reported near or total resolution of chest dysphoria, lack of regret, and improved quality of life and functioning.
We observed consensus that chest dysphoria is a major source of distress and can be functionally disabling to transmasculine youth. MCS performed during adolescence, including before age 18, can alleviate suffering and improve functioning. Additional research is needed to develop patient-reported outcome measures to assess the impact of chest dysphoria and MCS.
跨性别男性,即出生时被指定为女性但自我认同为男性的人,其自杀行为发生率较高,且常伴有胸部不适(对乳房发育的不期望而产生的不适和痛苦)。越来越多的跨性别男性青年正在寻求通过男性化胸部手术(MCS)进行确定性治疗,而成人研究表明 MCS 具有显著的益处,尽管人们对跨性别男性青年的胸部不适的影响或 MCS 的最佳时机知之甚少。在这项研究中,我们旨在探讨青年的胸部不适体验以及 MCS 的影响。
我们从一家儿童医院的性别诊所招募了年龄在 13 至 21 岁的跨性别男性青年。参与者完成了一项半结构化的定性访谈,探讨了胸部不适的体验,以及对 MCS 的想法或体验。访谈记录由 3 名研究人员进行编码,采用改良的扎根理论,中位数的组内相关系数为κ=0.92。
研究对象(n=30)的平均年龄为 17.5 岁,47%的人已接受 MCS。青年报告称,胸部不适会引发强烈的负面情绪和自杀意念,导致多种功能受限,且仅用睾丸酮治疗并不能充分缓解。所有接受 MCS 后的青年都报告称,胸部不适几乎或完全得到缓解,对手术没有遗憾,生活质量和功能得到改善。
我们观察到共识,即胸部不适是痛苦的主要来源,会对跨性别男性青年造成功能性障碍。青春期,包括 18 岁之前进行的 MCS,可以减轻痛苦并改善功能。需要进一步的研究来开发患者报告的结果测量工具,以评估胸部不适和 MCS 的影响。